Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.

Koster, Andreas; Fischer, Thomas; Gruendel, Marcus; Mappes, Andreas; Kuebler, Wolfgang M; Bauer, Matthias; Kuppe, Herman

Koster, Andreas; Fischer, Thomas; Gruendel, Marcus; Mappes, Andreas; Kuebler, Wolfgang M; Bauer, Matthias; Kuppe, Herman.

Affiliation

Koster A; Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany. Koster@dhzb.de

J Cardiothorac Vasc Anesth ; 17(2): 171-5, 2003 Apr.

Article in En | MEDLINE | ID: mdl-12698397

Subject(s)

Anticoagulants/therapeutic use; Cardiopulmonary Bypass; Drug Resistance/physiology; Hemostasis/drug effects; Heparin/therapeutic use; Tyrosine/analogs & derivatives; Aged; Antithrombins/therapeutic use; Blood Coagulation Factors/drug effects; Female; Fibrinolytic Agents/therapeutic use; Hirudin Therapy; Humans; Male; Middle Aged; Platelet Count; Prospective Studies; Tirofiban; Tyrosine/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Tyrosine / Drug Resistance / Heparin / Cardiopulmonary Bypass / Hemostasis / Anticoagulants Type of study: Clinical_trials / Observational_studies Language: En Journal: J Cardiothorac Vasc Anesth Year: 2003 Type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links